Anxiolytic- and antidepressant-like effects of new phenylpiperazine derivative LQFM005 and its hydroxylated metabolite in mice.

MLA

Moreira, Lorrane Kelle da Silva, et al. “Anxiolytic- and Antidepressant-like Effects of New Phenylpiperazine Derivative LQFM005 and Its Hydroxylated Metabolite in Mice.” Behavioural Brain Research, vol. 417, Jan. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bbr.2021.113582.

APA

Moreira, L. K. da S., Silva, R. R., da Silva, D. M., Mendes, M. A. S., de Brito, A. F., de Carvalho, F. S., Sanz, G., Rodrigues, M. F., da Silva, A. C. G., Thomaz, D. V., de Oliveira, V., Vaz, B. G., Lião, L. M., Valadares, M. C., Gil, E. de S., Costa, E. A., Noël, F., & Menegatti, R. (2022). Anxiolytic- and antidepressant-like effects of new phenylpiperazine derivative LQFM005 and its hydroxylated metabolite in mice. Behavioural Brain Research, 417, N.PAG. https://doi.org/10.1016/j.bbr.2021.113582

Chicago

Moreira, Lorrane Kelle da Silva, Rafaela Ribeiro Silva, Dayane Moreira da Silva, Mirella Andrade Silva Mendes, Adriane Ferreira de Brito, Flávio Souza de Carvalho, Germán Sanz, et al. 2022. “Anxiolytic- and Antidepressant-like Effects of New Phenylpiperazine Derivative LQFM005 and Its Hydroxylated Metabolite in Mice.” Behavioural Brain Research 417 (January): N.PAG. doi:10.1016/j.bbr.2021.113582.